Switzerland · Series A startup
One round we have observed, with the 10 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Mosanna Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 5 Nov 2026
$80Mraised across 1 round since 2025, from 1 source
Missing a round, or an investor who was in one? Tell us.
Mosanna Therapeutics's investors include EQT Life Sciences, Pivotal bioVenture Partners, Norwest Venture Partners, Forbion Capital Partners and HTGF High-Tech Gründerfonds, and 5 more on record. EQT Life Sciences led its latest round.
Mosanna Therapeutics has raised $80M across 1 round since 2025.
Mosanna Therapeutics's most recent round was a Series A of $80M in Jun 2025, led by EQT Life Sciences.
Its most recent round, $80M in Jun 2025, is also its largest on record.
Mosanna Therapeutics's first round on record, in Jun 2025, was backed by EQT Life Sciences, Pivotal bioVenture Partners and Norwest Venture Partners and 7 others.
Mosanna Therapeutics's latest named round is a Series A, in Jun 2025.
Mosanna Therapeutics is based in Switzerland.
EQT Life Sciences led the Series A in 2025.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Switzerland · 
